High blood glucose levels correlate with tumor malignancy in colorectal cancer patients

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 3825-3833

  Cui, Ge ^a   Zhang, Ting ^a   Ren, Fan ^a   Feng, Wen Ming ^a   Yao, Yunliang ^a   Cui, Jie ^b   Zhu, Guo Liang ^a   Shi, Qi Lin ^a  

^a HUZHOU UNIVERSITY   (China)

^b Zibo Hospital of Traditional Chinese Medicine Affiliated to Shandong University of TCM   (China)

Author keywords

Blood glucose; Colorectal neoplasms; Diabetes mellitus, type 2

Indexed keywords

ACARBOSE; GLIMEPIRIDE; METFORMIN; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; CANCER STAGING; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR DIFFERENTIATION; TUMOR VOLUME; BLOOD; COLORECTAL TUMOR; COMPLICATION; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; PATHOLOGY; SURVIVAL ANALYSIS;

BLOOD GLUCOSE; COLORECTAL NEOPLASMS; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 84949792669     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.894783     Document Type: Article

References (20)

1. International diabetes federation: IDF Diabetes Atlas. 4th ed. Brussels, Belgium: International Diabetes Federation; 2009. http://www.idf.org
2. Siegel R, Desantis C, Jemal A: Colorectal cancer statistics, 2014. Cancer J Clin, 2014; 64: 104–17
3. Mills KT, Bellows CF, Hoffman AE et al: Diabetes mellitus and colorectal cancer prognosis: a meta-analysis. Dis Colon Rectum, 2013; 56: 1304–19
4. Giouleme O, Diamantidis MD, Katsaros MG: Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms. World J Gastroenterol, 2011; 17: 444–48
5. Berster JM, Goke B: Type 2 diabetes mellitus as risk factor for colorectal cancer. Arch Physiol Biochem, 2008; 114: 84–98
6. Sun L, Yu S: Diabetes mellitus is an independent risk factor for colorectal cancer. Dig Dis Sci, 2012; 57: 1586–97
7. Chen KH, Shao YY, Lin ZZ et al: Type 2 diabetes mellitus is associated with increased mortality in chinese patients receiving curative surgery for colon cancer. Oncologist, 2014; 19: 951–58
8. Fan Y, Huang XD, Zhang H et al: Association between serum HbA1c levels and adenomatous polyps in patients with the type 2 diabetes mellitus. Minerva Endocrinol, 2015; 40(3): 163–67
9. Shin HY, Jung KJ, Linton JA, Jee SH: Association between fasting serum glucose levels and incidence of colorectal cancer in Korean men: the Korean Cancer Prevention Study-II. Metabolism, 2014; 63: 1250–56
10. Jullumstro E, Kollind M, Lydersen S, Edna TH: Diabetes mellitus and outcomes of colorectal cancer. Acta Oncol, 2009; 48: 361–67
11. Kramer HU, Muller H, Stegmaier C et al: Type 2 diabetes mellitus and gender- specific risk for colorectal neoplasia. Eur J Epidemiol, 2012; 27: 341–47
12. La Vecchia C, Negri E, Decarli A, Franceschi S: Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev, 1997; 6: 1007–10
13. Yang YX, Hennessy S, Lewis JD: Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology, 2004; 127: 1044–50
14. Flood A, Strayer L, Schairer C, Schatzkin A: Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control, 2010; 21: 1277–84
15. Zhang ZJ, Zheng ZJ, Kan H et al: Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis. Diabetes Care, 2011; 34: 2323–28
16. Edge SB, Compton CC: The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 2010; 17: 1471–74
17. Larsson SC, Orsini N, Wolk A: Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst, 2005; 97: 1679–87
18. Kabat GC, Kim MY, Strickler HD et al: A longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal women. Br J Cancer, 2012; 106: 227–32
19. Singh, S, Singh H, Singh PP et al: Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: A systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev, 2013; 22(12): 2258–68
20. Yin S, Bai H and Jing D: Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients: a systemic review and meta-analysis. Diagn Pathol, 2014; 9: 91 3833